Total Payments
$253,577
2024 Payments
$29,644
Companies
50
Transactions
1,385
Medicare Patients
10,329
Medicare Billing
$1.4M
Payment Breakdown by Category
Other$187,824 (74.1%)
Food & Beverage$37,735 (14.9%)
Travel$13,555 (5.3%)
Consulting$13,109 (5.2%)
Education$741.19 (0.3%)
Research$612.07 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $187,824 | 80 | 74.1% |
| Food and Beverage | $37,735 | 1,216 | 14.9% |
| Travel and Lodging | $13,555 | 62 | 5.3% |
| Consulting Fee | $13,109 | 6 | 5.2% |
| Education | $741.19 | 16 | 0.3% |
| Unspecified | $612.07 | 5 | 0.2% |
Payments by Type
General
$252,964
1,380 transactions
Research
$612.07
5 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $81,159 | 295 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $48,616 | 164 | $0 (2024) |
| GENZYME CORPORATION | $42,292 | 58 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $20,467 | 70 | $0 (2021) |
| Insmed, Inc. | $14,790 | 38 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $9,187 | 51 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $8,688 | 21 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $8,346 | 144 | $0 (2024) |
| Mylan Specialty L.P. | $6,215 | 45 | $0 (2023) |
| Genentech USA, Inc. | $2,476 | 92 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29,644 | 125 | GENZYME CORPORATION ($19,164) |
| 2023 | $25,700 | 172 | GENZYME CORPORATION ($11,520) |
| 2022 | $18,339 | 157 | GlaxoSmithKline, LLC. ($8,724) |
| 2021 | $25,833 | 167 | GlaxoSmithKline, LLC. ($11,265) |
| 2020 | $30,191 | 148 | GlaxoSmithKline, LLC. ($15,051) |
| 2019 | $69,253 | 264 | GlaxoSmithKline, LLC. ($37,449) |
| 2018 | $39,570 | 219 | Boehringer Ingelheim Pharmaceuticals, Inc. ($11,430) |
| 2017 | $15,046 | 133 | Sunovion Pharmaceuticals Inc. ($5,865) |
All Payment Transactions
1,385 individual payment records from CMS Open Payments — Page 1 of 56
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Pulmonology | ||||||
| 12/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 12/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.65 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/17/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Neurology | ||||||
| 12/09/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $35.97 | General |
| Category: Narcoplepsy | ||||||
| 12/05/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $27.74 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| 12/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: RESPIRATORY | ||||||
| 11/27/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,267.00 | General |
| Category: Immunology | ||||||
| 11/27/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $33.90 | General |
| Category: RESPIRATORY | ||||||
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.36 | General |
| Category: Cardiovascular | ||||||
| 11/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $100.26 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $29.33 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 11/19/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Neurology | ||||||
| 11/18/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $97.20 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $194.02 | General |
| 11/06/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.11 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $32.50 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 10/29/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $26.50 | General |
| Category: Narcoplepsy | ||||||
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $96.84 | General |
| 10/23/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $31.25 | General |
| Category: Cardiology | ||||||
| 10/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: RESPIRATORY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Clinical Outcomes Study to compare the effect of Fluticasone Furoate Vilanterol Inhalation Powder 100 25mcg with placebo on Survival in Subjects with moderate Chronic Obstructive Pulmonary Disease COPD and a history of or at increased risk for cardiov | GlaxoSmithKline, LLC. | $612.07 | 5 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 2,794 | 3,376 | $2.1M | $350,074 |
| 2022 | 19 | 2,737 | 3,378 | $2.3M | $372,138 |
| 2021 | 18 | 2,365 | 3,216 | $2.1M | $369,427 |
| 2020 | 19 | 2,433 | 3,062 | $2.0M | $312,767 |
Total Patients
10,329
Total Services
13,032
Medicare Billing
$1.4M
Procedure Codes
74
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 72 | 98 | $73,010 | $17,008 | 23.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 329 | 333 | $115,884 | $12,886 | 11.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 41 | 49 | $36,505 | $6,203 | 17.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 26 | 26 | $27,690 | $5,846 | 21.1% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2022 | 41 | 41 | $46,125 | $3,666 | 7.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 35 | 44 | $33,660 | $3,621 | 10.8% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 105 | 115 | $22,655 | $3,556 | 15.7% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2022 | 57 | 57 | $33,028 | $2,912 | 8.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 21 | 21 | $11,760 | $2,111 | 18.0% |
| 99407 | Smoking and tobacco use intensive counseling, more than 10 minutes | Office | 2022 | 32 | 37 | $5,365 | $1,266 | 23.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 14 | 47 | $12,925 | $649.40 | 5.0% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2022 | 17 | 18 | $1,530 | $335.48 | 21.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 693 | 1,282 | $705,100 | $154,493 | 21.9% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Office | 2021 | 69 | 69 | $318,159 | $41,050 | 12.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 219 | 219 | $212,904 | $33,950 | 15.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 269 | 363 | $136,125 | $29,691 | 21.8% |
| 95811 | Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube | Office | 2021 | 42 | 42 | $212,268 | $26,941 | 12.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 67 | 84 | $62,580 | $14,695 | 23.5% |
| 94729 | Measurement of lung diffusing capacity | Office | 2021 | 197 | 201 | $74,973 | $11,737 | 15.7% |
| 94726 | Determination of lung volumes using plethysmography | Office | 2021 | 197 | 200 | $68,200 | $10,892 | 16.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 72 | 87 | $45,740 | $10,335 | 22.6% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2021 | 207 | 215 | $74,820 | $9,893 | 13.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 66 | 85 | $36,275 | $7,003 | 19.3% |
| 95806 | Unattended sleep study with recording of heart rate, oxygen, respiratory airflow and effort | Office | 2021 | 68 | 136 | $77,565 | $6,692 | 8.6% |
| 94618 | Test for exercise-induced lung stress | Office | 2021 | 110 | 140 | $27,580 | $4,452 | 16.1% |
About Dr. Boris Sagalovich, MD
Dr. Boris Sagalovich, MD is a Pulmonary Disease healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1346391174.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Boris Sagalovich, MD has received a total of $253,577 in payments from pharmaceutical and medical device companies, with $29,644 received in 2024. These payments were reported across 1,385 transactions from 50 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($187,824).
As a Medicare-enrolled provider, Sagalovich has provided services to 10,329 Medicare beneficiaries, totaling 13,032 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Sleep Medicine, Sleep Medicine
- Location Brooklyn, NY
- Active Since 01/16/2007
- Last Updated 03/31/2021
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1346391174
Products in Payments
- NUCALA (Biological) $47,249
- DUPIXENT (Biological) $26,716
- TRELEGY ELLIPTA (Drug) $19,360
- Arikayce (Drug) $14,758
- ANORO (Drug) $12,855
- LONHALA MAGNAIR (Drug) $12,020
- UTIBRON (Drug) $8,303
- DUPIXENT DUPILUMAB INJECTION (Biological) $7,941
- Yupelri (Drug) $6,041
- BEVESPI AEROSPHERE (Drug) $5,388
- OFEV (Drug) $4,124
- SPIRIVA RESPIMAT (Drug) $2,866
- Xolair (Biological) $1,378
- STIOLTO RESPIMAT (Drug) $1,036
- WAKIX (Drug) $914.23
- TEZSPIRE (Biological) $789.01
- XYWAV (Drug) $783.86
- Wakix (Drug) $724.15
- SMARTVEST (Device) $716.36
- Esbriet (Biological) $687.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Brooklyn
Dr. Chaim Bernstein, M.d, M.D
Pulmonary Disease — Payments: $254,754
Pulmonary Disease $254,754
Dr. Maurice Alwaya, Md, MD
Pulmonary Disease — Payments: $22,286
Pulmonary Disease $22,286
Aron Rubin, Md, MD
Pulmonary Disease — Payments: $17,669
Pulmonary Disease $17,669
Elliott Bondi, Md, MD
Pulmonary Disease — Payments: $16,602
Pulmonary Disease $16,602
Dr. Mohammad Zaman, Md, MD
Pulmonary Disease — Payments: $12,861
Pulmonary Disease $12,861
Erum Zahid, Md, MD
Pulmonary Disease — Payments: $11,899
Pulmonary Disease $11,899